High Titer and Yield
SPT overexpression and pathway blocking dramatically increases the initial PS pool size, resulting in higher final recoverable yield.
Phytosphingosine (PS) is a naturally occurring long-chain sphingoid base with potent antimicrobial and anti-acne properties , making it a key component in advanced cosmetics and skincare, often used as a direct precursor for Ceramide production. Industrial production methods struggle with efficiency. Complex purification and low yield from traditional yeast extraction result in high manufacturing costs. Furthermore, Chemical synthesis is environmentally burdensome , requiring toxic reagents and leading to mixtures of less active stereoisomers. The biosynthetic approach focuses on enhancing the native yeast pathway, which is often limited by the activity of rate-limiting enzymes responsible for long-chain sphingolipid synthesis.
CD Biosynsis offers a comprehensive metabolic engineering solution, utilizing Saccharomyces cerevisiae (yeast) as the preferred host due to its native sphingolipid pathway. To significantly boost the final product titer, we Overexpress genes responsible for long-chain sphingolipid synthesis in yeast, such as Serine Palmitoyltransferase (Lcb 1/Lcb2) . SPT is the first and rate-limiting enzyme in the sphingoid base pathway; its overexpression drastically increases the flux from Serine and Palmitoyl-CoA to Phytosphingosine. In addition, we Optimize fermentation conditions and downstream processes to improve the efficiency of the in vitro synthesis and purification of non-natural long-chain sphingoid bases . This includes minimizing competing pathways and improving the desaturation (Des1) and hydroxylation (Sur2) steps needed to convert Sphinganine to the final Phytosphingosine structure, ensuring high yield and high stereoconfigurational purity.
Get a QuoteIndustrial Phytosphingosine production faces these key challenges:
A successful solution must ensure a massive supply of the sphingoid base precursor and prevent its diversion into complex lipids.
CD Biosynsis utilizes advanced metabolic engineering to optimize Phytosphingosine production in yeast:
Overexpress Key Enzymes (Lcb 1/Lcb2) for Precursor Boost
We overexpress the Lcb 1/Lcb2 (SPT) complex along with cofactors (Tsc3) to significantly increase the flux into the sphingoid base pathway.
Block Downstream Pathways to Prevent Product Diversion
We use gene knockouts (e.g., Lac 1/Lag1 Ceramide Synthases) to stop the conversion of PS to Ceramides , maximizing the free Phytosphingosine yield.
Optimize Fermentation and In Vitro Processes
We tune the growth environment and downstream hydrolysis protocols to maximize free PS recovery and purity of the bioactive isomer.
Fine-Tune Desaturation and Hydroxylation
We optimize the activity of Sur2 and Des1 genes to efficiently convert Sphinganine to Phytosphingosine with high specificity.
This integrated approach significantly increases the initial production rate and simplifies the final Phytosphingosine recovery.
Our Phytosphingosine engineering service is dedicated to pursuing the following production goals:
High Titer and Yield
SPT overexpression and pathway blocking dramatically increases the initial PS pool size, resulting in higher final recoverable yield.
High Bioactive Purity Icon
Enzymatic biosynthesis in yeast ensures the exclusive production of the D-erythro isomer , which is the highly active natural form, avoiding racemic mixtures.
Reduced Environmental Burden Icon
Microbial fermentation replaces multi-step chemical synthesis, eliminating the use of toxic reagents. [Image of Cost Reduction Icon]
Control Over Chain Length Icon
The system can be tuned to produce specific long-chain bases (C18, C20) by optimizing the fatty acid precursor supply.
Consistent Supply Chain Icon
Production is independent of seasonal variability and can be scaled to meet industrial demand reliably.
We provide a reliable, high-purity, and high-titer source for bioactive Phytosphingosine.
Our Phytosphingosine strain engineering service follows a rigorous, multi-stage research workflow:
Technical communication is maintained throughout the process, focusing on timely feedback regarding yield and product quality attributes.
Explore the potential for a high-titer, high-purity Phytosphingosine supply. CD Biosynsis provides customized strain and process engineering solutions:
Why is Serine Palmitoyltransferase (Lcb 1/Lcb2) overexpression critical?
The Lcb 1/Lcb2 complex is the rate-limiting enzyme in sphingolipid synthesis , catalyzing the first committed step. Overexpression ensures a large flow of precursors to the Phytosphingosine pathway, overcoming the natural bottleneck that causes low yield from extraction .
How do you prevent Phytosphingosine conversion to Ceramides?
In yeast, Phytosphingosine is primarily acylated by Ceramide Synthase enzymes (Lac 1/Lag1) to form Ceramides and complex sphingolipids. By knocking out these Ceramide Synthase genes, we block the acylation step , forcing the accumulation of the desired free Phytosphingosine product.
What is the advantage of enzymatic synthesis purity over chemical synthesis?
Enzymes are stereospecific. The native yeast enzymes produce the sphingoid base with the correct D-erythro stereoconfiguration , which is critical for biological activity. Chemical synthesis typically yields a mixture of isomers that must be separated, making it costly and resulting in a less active final product.
Why is Downstream Process Tuning needed?
Even with gene knockouts, a portion of the Phytosphingosine is often incorporated into complex lipids that remain in the cell membrane. Optimizing the hydrolysis protocol (e.g., base treatment) and extraction solvents is essential to cleave these complex lipids and achieve maximum recovery of the final free Phytosphingosine product.
What is the estimated project timeline?
A project involving multi-gene overexpression (Lcb 1/Lcb2, Sur2), multiple gene knockouts, and downstream process optimization typically requires 24-30 weeks for final industrial strain delivery and performance validation.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.